Ohio to name winners of up to $12M in opioid science grants

December 7, 2017

Ohio is set to name recipients of up to $12 million in competitive grants aimed at supporting scientific breakthroughs to solve the national opioid crisis.

The Third Frontier Commission is expected to announce grant winners Thursday.

The awards are part of Ohio's two-pronged strategy to drive innovative research and development in opioid and addiction science. The second element is an $8 million innovation challenge modeled after the Head Health competition launched by the NFL, Under Armour and GE to address traumatic brain injuries.

Ohio is among states hardest hit by the deadly opioid epidemic. It saw 4,050 last year, many linked to heroin and synthetic opioids like fentanyl.

Republican Gov. John Kasich (KAY'-sik) called in April for dedicating up to $20 million to the cause and accelerating distribution.

Explore further: Ohio seeks technology ideas to solve national opioid crisis

Related Stories

Ohio seeks technology ideas to solve national opioid crisis

October 18, 2017
Ohio launched an $8 million effort Wednesday to attract ideas for using technology to solve the national opioid addiction crisis that has touched scores of families, including that of Columbus mother Jacqueline Lewis, who ...

In Ohio, overdose deaths soared even with ad campaign

October 27, 2017
Anti-opioid abuse campaigns have targeted Ohio communities for years even as drug overdose deaths continue to soar in the hard-hit state. The effectiveness of such campaigns is under scrutiny as President Donald Trump proposes ...

Fentanyl in more than half of opioid deaths in 10 states

October 27, 2017
A federal report says the powerful painkiller fentanyl was involved in more than half of the recent opioid overdose deaths in 10 states.

CDC launches opioid campaign in hard-hit states

September 26, 2017
(HealthDay)—The U. S. Centers for Disease Control and Prevention has launched a campaign to reduce overdose deaths from prescription opioid painkillers.

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

High-tech ideas to fix opioid crisis compete for Ohio grants

August 8, 2017
A call by Republican Gov. John Kasich for scientific breakthroughs to help solve the opioid crisis is drawing interest from dozens of groups with ideas including remote controlled medication dispensers, monitoring devices ...

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.